No big losers this week so even more festive happiness.
IKA:Ilika climbed 7% this week but that wasn't enough to make up for the 9% drop last week. This one may yet make some money if the vehicle batteries come off, but I'm not holding out too much hope.
Share of the Week goes to OPTI:Optibiotix by a country mile, with a 16% increase being worth £10,500 and accounting for all the rise in the portfolio value. In fact there would have been a small loss without it, as many shares had small drops.
Boing!
Take that you evil trend line, and please start changing direction!
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £15.74 | +£0 | |
| Portfolio cost | £57,768.95 | +£0 | |
| Portfolio sell value (bid price-commission) | £41,263.95 | (-28.6%) | +£5,667.87 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£39.36 | (-0.8%) | +£2.07 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £405.97 | (8.4%) | -£1.79 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | 13.1% | +0% | |
| Compound performance | 57% | +0% |
Not much to report apart from a stonking great recovery in value, but still a fair way to go before being in profit, and still no positive sale this year despite being nearly half way through it. I'll be needing IQE:IQE to stage a recovery in order to make some profit as that's the one earmarked for sale.
Back above the injection line, but a long way below the cost line.
It remains to be seen whether this is the start of a recovery or a temporary blip.
The SIPP looks like this after week 212
| Weekly Change | ||||
| Cash | £90.96 | +£0 | ||
| Portfolio cost | £46,995.31 | +£0 | ||
| Portfolio sell value (bid price - commission) |
£37,904.61 | (-19.3%) | +£4,783.69 | |
| Potential profits | £722.97 | +£60.00 | ||
| Yr 5 Dividends | £0 | +£0 | ||
| Yr 5 Interest | £0 | +£0 | ||
| Yr 5 Profit from sales | £0 | +£0 | ||
| Yr 5 Average monthly cash profit | -£13.39 | (-0.3%) | +£4.47 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.17 | +£0 | ||
| Total Profit from sales | £12,549.10 | +£0 | ||
| Average monthly cash profit | £286.02 | (7.3%) | -£1.35 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Performance/Injection | 11.5% | +0% | ||
| Compound performance | 47% | +0% |
Another huge leap in value thanks to OPTI:Optibiotix and a small increase in potential profit thanks to CAML:Central Asia Metals. Average monthly profit for year 5 will remain negative as monthly charges are taken and until I sell something. MMX:Minds+Machines is still top candidate but needs evidence of profits and potentially a maiden dividend to convince the market that their low costs and recurring revenues have a long term future.
Back to half-way between injection and current cost
I need another 10p rise in OPTI:Optibiotix for that to get into profit, but most of the other shares are so bad at the moment it will take 10p on top of that to get back into the black.
Here's the trading account after week 178
| Weekly Change | |||
| Cash | £48.24 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,234.47 | (-46.8%) | -£7.60 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £2.60 | (1.3%) | -£0.12 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.40 | (-0.2%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | -0.2% | +0% | |
| Compound performance | -1% | +0% |
A small loss this week as the drop in IQE:IQE was greater than the rise in CAML:Central Asia Metals. Still no sign of being able to do anything interesting with this cursed account.
No dramas - just serial poor performance
Back below the pitiful trend line
Here's my virtual magic formula account performance
| Weekly Change | |||
| Cash | £153.61 | +£0 | |
| Portfolio cost | £29,846.39 | +£0 | |
| Portfolio sell value (bid price - commission) | £30,954.86 | (+3.2%) | +£230.32 |
| Potential profits | £1,080.87 | +£139.41 | |
| Year 1 Dividends | £0 | +£0 | |
| Year 1 Profit | £0 | +£0 | |
| Yr 1 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £0 | +£0 | |
| Profit from sales | £0 | +£0 | |
| Average monthly cash profit | £0 | (0%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
Portfolio value up by £230 and potential profits up by £139 so about half the rise is reduced losses. Best performing share is EVR:Evraz up 10.92% and worst performing is BMN:Bushveld Minerals which is down 16.57%. Only 6 of the shares are down since I bought them, and 24 are up. At the moment it's doing somewhat better than my real portfolio!
The same 30 companies are still at the top of the list, but the drop in share price has moved CAML:Central Asia Metals up to 31st and it only needs to move 6 places up the P/E ranking to enter the top 30.
KETL:Strix Group is 30th and so in most danger of falling out. At the moment my holding is making £65 (6.55%) profit. The rules of the magic formula are that you hold a share for a year before selling if it drops out of the top 30, but normally you would have bought gradually. My plan is to buy 2 every 4 months when I get my pension transfer, although I may buy some others when I sell existing holdings so I can get to 30 companies a bit quicker, as it will take 4 years at my current rate.
Meanwhile I'll be learning lots about the current top 30 with my virtual portfolio so I'll be ready to avoid any stinkers.
No comments:
Post a Comment